IPCA Laboratories Limited Financial Overview
IPCA Laboratories Limited's market cap is currently ₹362.90B. The company's EPS TTM is ₹13.1; its P/E ratio is 43.64; and it has a dividend yield of 0.28%. IPCA Laboratories Limited is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹9.10. See an overview of income statement, balance sheet, and cash flow financials.
